HyTriage

company

About

HyTriage is engages in research, development, production, and sales of in-vitro diagnostic reagents and inspection and analysis instruments.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
¥25M
Industries
Health Care,Health Diagnostics,Wellness
Founded date
Jan 1, 2013
Number Of Employee
51 - 100
Operating Status
Active

HyTriage is a Chinese healthcare service company, providing a chronic disease detection and management platform for children and the elderly.

HyTriage is engages in research, development, production, and sales of in-vitro diagnostic reagents and inspection and analysis instruments. Through cooperation with a number of in vitro diagnostic research institutions at home and abroad, it has successfully developed colloidal gold immunoassay analyzers, drug detectors, micro-net nebulizers, and lung function training devices.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥25M
HyTriage has raised a total of ¥25M in funding over 2 rounds. Their latest funding was raised on Mar 15, 2018 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 15, 2018 Series B ¥25M 1 Yahui Precision Medicine Fund Detail

Investors

Number of Lead Investors
Number of Investors
1
1
HyTriage is funded by 1 investors. Yahui Precision Medicine Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Yahui Precision Medicine Fund Yes Series B